Havrilesky, L. J., Yang, J. C., Lee, P. S., Secord, A. A., Ehrisman, J. A., Davidson, B., … Reed, S. D. (2019). Patient Preferences for Attributes of Primary Surgical Debulking Versus Neoadjuvant Chemotherapy for Treatment of Newly Diagnosed Ovarian Cancer. Obstetrical and Gynecological Survey, 74(12), 718–719. https://doi.org/10.1097/OGX.0000000000000743

Havrilesky, L. J., J. C. Yang, P. S. Lee, A. A. Secord, J. A. Ehrisman, B. Davidson, A. Berchuck, K. M. Darcy, G. L. Maxwell, and S. D. Reed. “Patient Preferences for Attributes of Primary Surgical Debulking Versus Neoadjuvant Chemotherapy for Treatment of Newly Diagnosed Ovarian Cancer.” Obstetrical and Gynecological Survey 74, no. 12 (December 1, 2019): 718–19. https://doi.org/10.1097/OGX.0000000000000743.

Havrilesky LJ, Yang JC, Lee PS, Secord AA, Ehrisman JA, Davidson B, et al. Patient Preferences for Attributes of Primary Surgical Debulking Versus Neoadjuvant Chemotherapy for Treatment of Newly Diagnosed Ovarian Cancer. Obstetrical and Gynecological Survey. 2019 Dec 1;74(12):718–9.

Havrilesky, L. J., et al. “Patient Preferences for Attributes of Primary Surgical Debulking Versus Neoadjuvant Chemotherapy for Treatment of Newly Diagnosed Ovarian Cancer.” Obstetrical and Gynecological Survey, vol. 74, no. 12, Dec. 2019, pp. 718–19. Scopus, doi:10.1097/OGX.0000000000000743.

Havrilesky LJ, Yang JC, Lee PS, Secord AA, Ehrisman JA, Davidson B, Berchuck A, Darcy KM, Maxwell GL, Reed SD. Patient Preferences for Attributes of Primary Surgical Debulking Versus Neoadjuvant Chemotherapy for Treatment of Newly Diagnosed Ovarian Cancer. Obstetrical and Gynecological Survey. 2019 Dec 1;74(12):718–719.